Regency Fincorp Limited has successfully completed the allotment of 25,000 non-convertible debentures (NCDs) worth ₹25 crores through private placement. The Board of Directors approved this allotment during their meeting held on March 23, 2026, concluding at 1:45 PM.

Board Meeting Outcome and Regulatory Compliance

Pursuant to Regulation 30 read with Schedule III of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has formally communicated the board meeting outcome to BSE Limited. The board considered and approved the allotment of 25,000 fourteen percent Listed, Secured, Rated, Redeemable Non-Convertible Debentures through private placement.

Terms and Features

The NCDs are structured as 14% Listed, Secured, Rated, Redeemable Non-Convertible Debentures issued through private placement to identified investors. These securities will be listed on BSE Limited, providing liquidity options for the investor.

Payment Schedule Structure

The debentures feature a structured payment mechanism with both interest and principal payments scheduled quarterly. The payment schedule includes five coupon payments and five principal payments spread across the 15-month tenor.

Coupon Payment Schedule

Principal Repayment Schedule

The principal amount will be repaid in five equal installments of ₹5 crores each, aligned with the coupon payment dates from June 23, 2026, through June 23, 2027.

Security and Risk Management

The NCDs are secured with a comprehensive security cover of 1.25 times the amounts outstanding under the debentures. This security cover includes interest, default interest, trustee remuneration, charges, fees, expenses, and other applicable charges. At least 125% of the security cover comprises principal receivables, providing additional protection to the investor.

In case of payment defaults, the company will be liable to pay a penalty of 5% per month over the applicable coupon rate on the outstanding principal amount for the period of default. No cure period is applicable for payment defaults, ensuring strict adherence to payment schedules.

Management Authorization

The allotment was formally authorized by Gaurav Kumar, Managing Director (DIN: 06717452), who digitally signed the board meeting outcome communication. The disclosure was made in compliance with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Regency Fincorp Limited has announced that its Board of Directors will convene on March 25, 2026, to consider several important corporate matters related to capital structure and fund raising activities. The meeting notice was issued on March 21, 2026, in compliance with SEBI regulations.

Key Agenda Items

The board meeting will address multiple strategic initiatives aimed at strengthening the company's financial position and operational framework:

Fund Raising Initiatives

The company plans to explore multiple avenues for capital mobilization. The board will consider issuing equity shares on a preferential basis, which could provide the company with additional working capital for its operations. Furthermore, the company is evaluating the issuance of debt instruments including both listed and unlisted securities.

The proposed debentures and commercial papers will be offered on a private placement basis to both resident and non-resident investors. These instruments may be structured as secured or unsecured redeemable non-convertible securities, providing flexibility in terms of investor preferences and market conditions.

Corporate Governance and Compliance

The meeting notice was issued under Regulation 29 and 50 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Company Secretary and Compliance Officer Abhimanyu signed the notice, ensuring adherence to regulatory requirements.

Regency Fincorp Limited, formerly known as Regency Investments Limited, operates from its corporate and registered office located in Zirakpur, Punjab. The company maintains its listing on BSE Limited with scrip code 540175.